Arthritis research shows better management more important than new drugs

Nov 26, 2008

Although there has been an increase in the number of new arthritis treatments in recent years, the best results will come from more effective use of the drugs we have. Research published today in BioMed Central's open access journal Arthritis Research and Therapy investigates the effectiveness of available arthritis drugs and concludes that better management is the most important factor.

Isidoro González-Alvaro from the Hospital Universitario de la Princesa, Spain, led a team of researchers who studied the treatment of 789 patients over four years between 2000 and 2004. He said, "Our work shows that the treatment of rheumatoid arthritis at tertiary hospitals in Spain has improved from the year 2000. It is likely that better management of available drugs, mainly methotrexate, has been learned during the last decade - along with the clinical development of most biologic agents."

The management of rheumatoid arthritis (RA) has changed a great deal over the last 10 years. The development of biologic therapies, as well as the rigorous clinical trials that have demonstrated their effectiveness, have probably contributed to this change. However, according to González-Alvaro, "In our study, we did not observe the amazing halt of radiological progression described in clinical trials."

When used outside trials, the effectiveness of new drugs may differ, since patients included in clinical trials are on average younger, have less comorbidity, and show greater disease activity than real-life patients. In order to ascertain the real-life effectiveness of new RA medication, the authors studied RA patients in terms of disease activity, disability and radiological progression in the period after the Spanish launch of Leflunomide and the TNF antagonists. They write, "The most relevant finding of our work is that disease activity in RA has improved, independently of the availability of new therapies, in patients with severe and mild disease."

The authors conclude, "It is clear that we need specific markers of RA severity that allow us to select adequate patients for early biologic treatment in order to improve their therapeutic response, as well as their functional outcome. These tools may also help to improve cost-effectiveness of these drugs avoiding unnecessary prescriptions."

Source: BioMed Central

Explore further: In US, Ebola fears rise but most confident in response

add to favorites email to friend print save as pdf

Related Stories

Quantum effects in nanometer-scale metallic structures

20 minutes ago

Plasmonic devices combine the 'super speed' of optics with the 'super small' of microelectronics. These devices exhibit quantum effects and show promise as possible ultrafast circuit elements, but current ...

Why has Halloween infiltrated Australian culture?

30 minutes ago

Halloween appears to have infiltrated Australian culture, and according to a University of Adelaide researcher, the reason for its increasing popularity could run much deeper than Americanisation.

Historical comet-landing site is looking for a name

30 minutes ago

The Rosetta mission reaches a defining moment on Wednesday November 12, when its lander, Philae, is released. After about seven hours of descent, Philae will arrive on the surface of Comet 67P Churyumov-Gerasimenko. ...

Research unlocks potential of super-compound

30 minutes ago

Researchers at The University of Western Australia's have discovered that nano-sized fragments of graphene - sheets of pure carbon - can speed up the rate of chemical reactions.

Recommended for you

In US, Ebola fears rise but most confident in response

4 hours ago

After two health care workers in Texas were infected with Ebola while caring for a Liberian patient, a poll Tuesday showed a rattled US public that nevertheless stayed confident in the government's response.

'Humbled' NBC cameraman recovers from Ebola

5 hours ago

A US photojournalist said Tuesday he was grateful to be alive after the hospital treating him declared him now free of Ebola, in a minor victory over the virus that has killed more than 4,500 people.

User comments : 0